Vasogen-- VAS on TSE Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Vasogen-- VAS on TSE

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: ddl who wrote (336)	8/4/2005 3:32:11 PM
From: Clarksterh	of 377

The poinyts he is bringing up have been disgussed on this board and, therefore, I do not believe he is bringing anything really new to the table except to put a negative slant on everything. This is true and offsets, to some degree, the negative that the placebo group has such a high event rate. But not entirely. The fact that the placebo group was so low tells you that this may not be repeatable. That it was an atypical group. This is similar to the problem of improved SoC killing a well designed ph iii (see Citicoline trials in stroke - between the ph ii and the ph iii the widespread use of clot busters started.). Clark

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next